The global plasma fractionation market was valued at $18,222 million in 2019, and is expected to reach $23,006 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. Surge in geriatric ...

Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. It is used to prevent formation of blood clots caused by certain ...

A February 2025 study, conducted by two researchers based at the University of Mosul’s Department of Pharmaceutical Chemistry ...

Columnist G. Shellye Horowitz chats with Hannes Jung, creator of the Bleeder app, which helps hemophilia patients track ...

Apyx Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of a proprietary helium plasma ...

Sepsis is one of the deadliest conditions in intensive care units (ICUs), triggered by the body's out-of-control response to ...

In a recent development, researchers have created an AI-driven model capable of predicting mortality risk in sepsis patients ...

Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that enhance therapeutic efficacy across oncology, autoimmune disorders, and ra | ...

Kedrion Biopharma Inc. expands the distribution network for Ryplazim, a plasma-derived human plasminogen indicated for treating patients with plasminogen deficiency type 1 (PLGD-1). This expansion ...

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

The global hemostatic gels market is on a steady growth path, with its value projected to reach USD 1.9 billion by 2032. With rising surgical procedures, increasing trauma cases, and continuous ...